Recursion Pharmaceuticals (RXRX) is up 12.9%, or 54c to $4.74. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top stocks ...
Recursion Pharmaceuticals Inc (NASDAQ: RXRX) shares moved higher Wednesday after JPMorgan upgraded the stock to Overweight from Neutral and lifted its price target to $11 from $10. What Happened: ...
His job is to reimagine the future of drugmaking using that similarly trendy branch of computer science, artificial ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈